BackAcurx Pharmaceuticals Overview

Acurx Pharmaceuticals Current Cash

Track Acurx Pharmaceuticals's current cash ($9.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$9.25M
99.80% YoYΔ $-4.63B vs prior year quarter

Peer average

Loading

Acurx Pharmaceuticals Current Cash History

Loading

Acurx Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Acurx Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acurx Pharmaceuticals (ACXP) FAQ

As of the most recent data (March 2026), ACXP shows a current cash of $9.3M. That compares with $4.6B in the prior-year period — down 99.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACXP's current cash is now $9.3M (was $4.6B) — a 99.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Acurx Pharmaceuticals is outperforming or lagging.

Tracking ACXP's current cash over time shows whether Acurx Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $9.3M That compares with $4.6B in the prior-year period — down 99.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Acurx Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $9.3M) with ownership activity and broader fundamentals.

Acurx Pharmaceuticals's current cash is $9.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.